Advanced search
Publication Cover
Journal of Obstetrics and Gynaecology Volume 35, 2015 - Issue 7
Submit an article Journal homepage
152
Views
3
CrossRef citations to date
0
Altmetric
OBSTETRICS

Increased first-trimester nuchal translucency associated with thanatophoric dysplasia type 1

L. ZhenPrenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China
,
M. PanPrenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China
,
J. HanPrenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China
,
X. YangPrenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China
,
C. LiaoPrenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China
&
D. Z. LiPrenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, ChinaCorrespondence[email protected]
Pages 685-687 | Published online: 11 Feb 2015

References

  • Avgidou K, Papageorghiou A, Bindra R, Spencer K, Nicolaides KH. 2005. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. American Journal of Obstetrics and Gynecology 192:1761–1767.
  • Ayräs O, Tikkanen M, Eronen M, Paavonen J, Stefanovic V. 2013. Increased nuchal translucency and pregnancy outcome: a retrospective study of 1063 consecutive singleton pregnancies in a single referral institution. Prenatal Diagnosis 33:856–862.
  • Barbosa-Buck CO, Orioli IM, Dutra MG, Lopez-Camelo J, Castilla EE, Cavalcanti DP. 2012. Clinical epidemiology of skeletal dysplasias in South America. American Journal of Medical Genetics. Part A 158A: 1038–1045.
  • Bilardo CM, Muller MA, Pajkrt E, Clur SA, van Zalen MM, Bijlsma EK. 2007. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound in Obstetrics & Gynecology 30:11–18.
  • Bilardo CM, Timmerman E, Pajkrt E, van Maarle M. 2010. Increased nuchal translucency in euploid fetuses--what should we be telling the parents? Prenatal Diagnosis 30:93–102.
  • Buyse ML. 1990. Birth defects encyclopedia. Cambridge, Blackwell Scientific Medical Publications 1661–1662.
  • Chen CP, Chern SR, Shih JC, et al. 2001. Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia. Prenatal Diagnosis 21:89–95.
  • Doray B, Favre R, Viville B, Langer B, Dreyfus M, Stoll C. 2000. Prenatal sonographic diagnosis of skeletal dysplasias. A report of 47 cases. Annales de Genetique 43:163–169.
  • Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH. 2006. Relation between increased fetal nuchal translucency thickness and chromosomal defects. Obstetrics.and Gynecology 107:6–10.
  • Khalil A, Pajkrt E, Chitty LS. 2011. Early prenatal diagnosis of skeletal anomalies. Prenatal Diagnosis 31:115–124.
  • Leung TY, Vogel I, Lau TK, et al. 2011. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Ultrasound in Obstetrics & Gynecology 38:314–319.
  • Liu YN, Li R, Li DZ. 2011. Genotyping of the C742T mutation of the FGFR3 gene causing type 1 thanatophoric dysplasia by high-resolution melting analysis. The Journal of Maternal-Fetal & Neonatal Medicine 24:186–188.
  • Maymon R, Zimerman AL, Weinraub Z, Herman A, Cuckle H. 2008. Correlation between nuchal translucency and nuchal skin-fold measurements in Down syndrome and unaffected fetuses. Ultrasound in Obstetrics & Gynecology 32:501–505.
  • Passos-Bueno MR, Wilcox WR, Jabs EW, Sertie AL, Alonso LG, Kitoh H. 1999. Clinical spectrum of fibroblast growth factor receptor mutations. Human Mutation 14:115–125.
  • Rousseau F, Saugier P, Le Merrer M, Munnich A, Delezoide AL, Maroteaux P, et al. 1995. Stop codon FGFR3 mutations in thanatophoryc dwarfism type1. Nature Genetics 10:11–12.
  • Spranger J, Maroteaux P. 1990. The lethal osteochondrodysplasias. Advances in Human Genetics 19:1–103.
  • Vossen RH, Aten E, Roos A, den Dunnen JT. 2009. High-resolution melting analysis (HRMA): more than just sequence variant screening. Human Mutation 30:860–866.
  • Yang Y, Li D. 2009. FGFR3 gene mutations in Chinese cases of thanatophoric dysplasia type 1. Fetal Diagnosis and Therapy 26:90–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.